New drug targets immune system to treat rare kidney diseases
NCT ID NCT05083364
First seen Dec 16, 2025 · Last updated Apr 29, 2026 · Updated 21 times
Summary
This study tested a new drug called ARO-C3 in 62 healthy adults and people with two types of kidney disease (C3 glomerulopathy and IgA nephropathy). The goal was to see if the drug is safe and how it works in the body. Participants received either the drug or a placebo, and the results will help guide future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGA NEPHROPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Auckland, 1010, New Zealand
-
Research Site 1
Camperdown, New South Wales, 2050, Australia
-
Research Site 1
Gamcheon, Busan, 49267, South Korea
-
Research Site 2
Clayton, Victoria, 3168, Australia
-
Research Site 2
Tbilisi, 0112, Georgia
-
Research Site 2
Cologne, 50937, Germany
-
Research Site 2
Haeundae, Busan, 48108, South Korea
-
Research Site 2
Bangkok, 10400, Thailand
-
Research Site 3
Concord, New South Wales, 2139, Australia
-
Research Site 3
Daegu, Daegu, 42601, South Korea
-
Research Site 3
Chiang Mai, 50200, Thailand
-
Research Site 4
Erlangen, 91054, Germany
-
Research Site 4
Goyang-si, Gyeonggi-do, 10444, South Korea
-
Research Site 4
Oxford, OX3 7LE, United Kingdom
-
Research Site 6
Soeul, 03722, South Korea
-
Research Site 8
Soeul, 05030, South Korea
Conditions
Explore the condition pages connected to this study.